Stocks
Denali Therapeutics (DNLI) Debt/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | 2.79 | 3.86 | 5.46 | 1.59 | 1.66 | 1.81 | ||
| Changes by years, y/y, % | -112% | +38% | +41% | -71% | +4% | |||
Denali Therapeutics. Debt/EBITDA
Denali Therapeutics. Debt/EBITDA, changes, %
Denali Therapeutics (DNLI) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 1.52 | 1.63 | 1.50 | 1.55 | 1.81 | 1.81 | ||
| Changes by years, y/y, % | -66% | -6% | -5% | -2% | +19% | |||
| Changes by quarters, q/q, % | -4% | +7% | -8% | +3% | +17% | |||
